Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sangamo BioSciences
Sangamo BioSciences
Despite Late-Stage Hemophilia Win, Sangamo Remains in Do-or-Die Situation
BioSpace
Wed, 07/31/24 - 10:48 am
Sangamo BioSciences
Pfizer
hemophilia A
gene therapy
Sangamo Biosciences on the Brink: Cash Crunch Could Lead to Bankruptcy by Q3 2024
Tip Ranks
Fri, 03/15/24 - 10:55 am
Sangamo BioSciences
bankruptcy
ASH preview – waiting for Editas
EP Vantage
Wed, 11/9/22 - 10:40 am
ASH 2022
sickle cell disease
Bluebird Bio
Sangamo BioSciences
Novartis
Editas Medicine
gene therapy
Vertex Pharmaceuticals
Sanofi
ESGCT 2022 – Sangamo strengthens its case in Fabry
EP Vantage
Thu, 10/13/22 - 09:11 am
Sangamo BioSciences
Fabry disease
ESGCT
ST-920
Sangamo presses ahead with Fabry disease gene therapy
BioPharma Dive
Thu, 09/1/22 - 07:50 pm
Sangamo BioSciences
Fabry disease
clinical trials
Pfizer, Sangamo flesh out hemophilia gene therapy data ahead of phase 3
Fierce Biotech
Thu, 06/18/20 - 10:38 am
Pfizer
Sangamo BioSciences
hemophilia A
clinical trials
gene therapy
giroctocogene fitelparvovec
Sangamo Stock Soars on Positive Hemophilia Treatment Trial
TheStreet.com
Tue, 04/2/19 - 11:59 am
Sangamo BioSciences
Pfizer
SB-525
hemophilia
clinical trials
Sangamo Sinks Most in a Decade as Gene-Editing Study Fizzles
Bloomberg
Thu, 02/7/19 - 03:30 pm
Sangamo BioSciences
clinical trials
gene editing
CRIPSR
MPS II
[video+transcript] Gene-Editing Stocks Took Stutter Steps Forward in 2018
Motley Fool
Tue, 12/18/18 - 10:34 am
gene editing
Editas
Vertex Pharmaceuticals
CRISPR Therapeutics
Sangamo BioSciences
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M
Xconomy
Mon, 07/23/18 - 10:24 pm
Sangamo BioSciences
M&A
TxCell
autoimmune disease
cell therapy
3 Biotech Stocks That Have Already Quadrupled in 2017
Stat
Wed, 09/13/17 - 09:33 pm
biotech
Kite Pharma
Sangamo BioSciences
Dynavax Technologies
3 Biotech Stocks That Skyrocketed This Past Week
Motley Fool
Mon, 09/4/17 - 10:07 am
Abeona Therapeutics
EB-101
Sangamo BioSciences
SB-525
Juno Therapeutics
CAR-T
5 Best Biotech Stocks of 2017 So Far
Motley Fool
Mon, 06/26/17 - 09:41 am
biotech
Alnylam
Puma Biotechnology
Immunogen
Sangamo BioSciences
Calitera
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Endpoints
Thu, 05/11/17 - 11:21 am
Pfizer
gene therapy
hemophilia
Sangamo BioSciences
SB-525
hemophilia A
These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences
3 Biotechs That Could Change Medicine Forever: Wasatch Analyst Jill Wahleithner
Seeking Alpha
Fri, 03/27/15 - 10:22 am
biotech
Argos Therapeutics
Inovio
Sangamo BioSciences
Study of potential HIV 'cure' wins FDA nod
Bizjournals.com
Wed, 03/4/15 - 08:16 am
FDA
HIV
Sangamo BioSciences
gene editing
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Mon, 07/21/14 - 09:17 am
Alzheimer's disease
pimavanserin
Acadia
Sangamo BioSciences
Valeant Pharmaceuticals
Bexarotene
Merck
BACE inhibitors
AstraZeneca
solanezumab
Eli Lilly
This Week in Biotech: Put It in Print
Motley Fool
Sun, 03/9/14 - 01:31 pm
Endo
Aveed
Rigel Pharmaceuticals
R118
Sangamo BioSciences
SB-728-T
NewLink Genetics
Xoma
gevokizumab
Pages
1
2
3
4
next ›
last »